GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals PLC (XPAE:PHARMACARE) » Definitions » Total Stockholders Equity

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals (XPAE:PHARMACARE) Total Stockholders Equity : $24.77 Mil (As of Dec. 2021)


View and export this data going back to 2013. Start your Free Trial

What is Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Total Stockholders Equity?

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Total Stockholders Equity for the quarter that ended in Dec. 2021 was $24.77 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2021 was $2.75. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Debt-to-Equity for the quarter that ended in Dec. 2021 was 0.35.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Total Stockholders Equity Historical Data

The historical data trend for Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Total Stockholders Equity Chart

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.40 25.53 18.85 19.11 24.77

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Sep21 Dec21
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.79 19.11 32.09 39.09 24.77

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals  (XPAE:PHARMACARE) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Book Value per Share for the quarter that ended in Dec. 2021 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Debt-to-Equity for the quarter that ended in Dec. 2021 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 677, Ramallah, PSE
Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals PLC is engaged in the manufacturing, selling, distribution, export and import of medicines, cosmetics, chemicals and veterinary products.

Dar Al-Shifa'a for the Manufacturing of Pharmaceuticals Headlines

No Headlines